These findings in normal mouse and human tissues were in striking contrast to the potent anti-proliferative, apoptotic effect of CDDD11-8 in the cancer cells and highlights the improved selectivity of this drug, a critical feature for targeting pan-essential genes like CDK9 in the treatment of cancer [49]. This evidence concerns the gene CDK9 and cancer.